Amos Sommer, Ph.D is the current Chief Technology Officer, COO, and Acting CEO at DiagnosTear Ltd. Amos has also founded companies such as Rapid BioScience and serves as the Chief Scientific Officer and co-Founder at Rapid BioPass. With a background in Biology and extensive experience in research and development, Amos has been instrumental in developing innovative diagnostic kits and rapid tests for various medical conditions, including HIV and COVID-19. Their expertise and leadership have been pivotal in the success of the companies Amos has worked with.
Org chart
Sign up to view 1 direct report
Get started
Teams
This person is not in any teams
